期刊文献+

硒与自身免疫性甲状腺疾病 被引量:4

Selenium and autoimmune thyroid disease
原文传递
导出
摘要 硒作为人体必需的一种微量元素,在机体中参与甲状腺激素的合成、活化及代谢,从而影响甲状腺功能。在自身免疫性甲状腺疾病(AITD)中,硒的水平低于正常值。低硒可能通过影响甲状腺的滤泡上皮细胞内多种含硒蛋白酶和(或)影响机体的免疫功能而导致AITD的发生与发展。给AITD患者补硒,为该病的治疗和预后开辟了一条新路。 As one of the essential trace elements, selenium takes part in the synthesis, activation and metabolism of thyroid hormones so as influencing thyroid function. In autoimmune thyroid disease, the level of selenium is lower than normal. The low serum selenium level may have impact on the multiple selenoproteinase on the surface of follicular epithelial cell or on the immune system of the body resuhing in the occurrence and progression of thyroid disease. Selenium supplementation should be one of the potential and new measures for the prevention and therapy of autoimmune thyroid disease.
作者 张怡 袁卫红
出处 《国际放射医学核医学杂志》 2012年第6期376-379,共4页 International Journal of Radiation Medicine and Nuclear Medicine
关键词 自身免疫 甲状腺疾病 Selenium Autoimmune Thyroid disease
  • 相关文献

参考文献32

  • 1Schwarz K, Foltz CM. Factor 3 activity of selenium compounds. J Biol Chem, 1958, 233( 1 ) : 245-251.
  • 2Rotruck JT, Pope AL, Ganther HE, et al. Selenium: biochemical role as a component of giutathion peroxidase. Science, 1973, 179 (4073): 588-590.
  • 3Kvicala J. Selenium and the organism. Cas Lek Cesk, 1999, 138 (4): 99-106.
  • 4Combs GF, Clarck LC, Turn bull BW. An analysis of cancer prevention by selenium. Biofactors, 2001, 14(1-4) : 153-159.
  • 5Rayman MP. The importance of selenium to human health. Lancet, 2000, 356(9225) : 233-241.
  • 6Bleys J, Navas-Acien A, Guallar E. Serum selenium levels and allcause, cancer, and cardiovascular mortality among US adults. Arch Intern Med, 2008, 168(4): 404-410.
  • 7Beckett GJ, Arthur JR. Selenium and endocrine systems. J Endocrinol, 2005, 184(3) : 455-465.
  • 8Kohrle J, Gartner R. Selenium and thyroid. Best Pract Res Clin Endocrinol Metab, 2009, 23(6): 815-827.
  • 9Przybyhk-Mazurek E, Zagrodzki P, Kuzniarz-Rymarz S, et al. Thyroid disorders-assessments of trace elements, clinical, and laboratory parameters. Biol Trace Elem Res, 2011, 141 ( 1-3 ) : 65-75.
  • 10Miranda SG, Purdie NG, Osborne VR, et al. Selenomethionine increases proliferation and reduces apoptosis in bovine mammary ep- ithelial cells under oxidative stress. J Dairy Sci, 2011, 94 ( 1 ) : 165-173.

二级参考文献9

  • 1张国龙,光山正雄,杜长梅,石瑞如,王江东,高飞絮,张霞.结核患者Th1/Th2细胞因子和前炎性因子研究[J].山东医药,2005,45(28):11-12. 被引量:3
  • 2刘莉,平智广,朱本章.自身免疫性甲状腺病患者血清硒水平[J].中华内分泌代谢杂志,2005,21(6):537-538. 被引量:24
  • 3John RA, Roderick C, Mckenzie, et al. Selenium in the immune sys- tem. J Nutr, 2003,133:1457S-1459S.
  • 4Geoffrey JB, John RA. Selenium and endocrine systems. J Endocrinol, 2005,184:455-465.
  • 5Leonidas HD, Emilla M, Demetrios AK. Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. Eur Endo- crinol, 2003,148:389-393.
  • 6Roland G, Barbara CH, Gasnier J, et al. Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidese antibodies concentrations. J Clin Endocrinol Metab, 2002,87:1687-1691.
  • 7Watson PF, Pickerill AP, Davies, et al. Analysis of cytokine gene expression in Graves'disease and mutinodular goiter[ J]. J Clin Endoer, 1994, 79(2) :355-360.
  • 8Kocjan T, Wraber B, Kocijancic A, et al. Methimaznle upregulates T-cell-derived cytokines without improving the existing Th1/Th2 imbalance in Graves'disease[J]. J Endocrinol Invest. 2004, 27(4) : 302-307.
  • 9汪新宇,李全忠,文世林,王桂兰,田志刚.Graves眼病Th_1/Th_2相关细胞因子群谱的特征[J].中华内分泌代谢杂志,2000,16(3):150-152. 被引量:11

共引文献23

同被引文献57

  • 1张洁红,张彤,段敏虹,陈广原.硒对成人桥本甲状腺炎的影响[J].中国实用医刊,2010,37(9):40-41. 被引量:2
  • 2刘莉,平智广,朱本章.自身免疫性甲状腺病患者血清硒水平[J].中华内分泌代谢杂志,2005,21(6):537-538. 被引量:24
  • 3中国甲状腺疾病诊治指南——甲状腺功能亢进症[J].中华内科杂志,2007,46(10):876-882. 被引量:853
  • 4Tomer Y. Mechanisms of autoimmune thyroid diseases : from ge- netics to epigenetics [ J ]. Annu Rev Pathol, 2014,9 : 147-156.
  • 5Duntas LH. Selenium and the thyroid: a close-knit connection [ J]. J Clin Endocrinol Metab, 2010,95 ( 12 ) :5180-5188. DOI : 10. 1210/jc. 2010-0191.
  • 6Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary [J]. Control Clin Trials, 1996,17( 1 ) :1-12.
  • 7Gartner R, Gasnier BC, Dietrich JW, et al. Selenium supple- mentation in patients with autoimmune thyroiditis decreases thy- roid peroxidase antibodies concentrations [ J ]. J Clin Endocrinol Metab ,2002,87 (4) : 1687-1691.
  • 8Duntas LH, Mantzou E, Koutras DA. Effects ot" a six month treat- ment with selenomethionine in patients with autoimmune thyroidi- tis[J]. Eur J Endocrinol,2003,148(4) :389-393.
  • 9Gartner R, Gasnier BC. Selenium in the treatment of autoimmune thyroiditis [ J ]. Biofactors ,2003,19 ( 3-4 ) : 165-170.
  • 10Turker O, Kumanlioglu K, Karapolat I,et al. Selenium treatment in autoimmune thyroiditis: 9-month follow-up with variable doses [ J]. J Endocrino1,2006,190 ( 1 ) : 151-156.

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部